top of page

GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML

Product details

Registration number: SIN14827P

Classification: Prescription Only

Active ingredients: Obinutuzumab

Strength: 1000 mg/40 mL

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: L01FA03

HSA approval date: 13 August 2015

Manufacturer(s): Roche Diagnostics GmbH

Manufacturing country/countries: GERMANY

What are the HSA registration number and classification for GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14827P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Obinutuzumab

Strength: 1000 mg/40 mL

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML?

According to the HSA dataset updated 7 August 2026:

Registrant: ROCHE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Roche Diagnostics GmbH

Manufacturing country/countries: GERMANY

Source for this answer

Where can I look up GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14827P or the exact product name GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this GAZYVA CONCENTRATE FOR SOLUTION FOR INFUSION 1000MG/40ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14827P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page